Center for Scientific Review; Notice of Closed Meetings, 57209-57210 [2022-20219]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 180 / Monday, September 19, 2022 / Notices
FDA estimates that 59 recordkeepers
will keep a total of about 89 records at
3 hours per record for a total of 267
hours. As stated previously, these
estimates are based on FDA’s experience
with information collections for other
tobacco product plans (i.e., smokeless,
OMB control number 0910–0671 and
cigars, OMB control number 0910–
0768). Based on our estimates for the
submission of one-time, initial plans
and supplements (i.e., that all
respondents will submit one-time,
initial plans and about half of
respondents will submit supplements to
FDA-approved plans), we estimate that
each recordkeeper will keep an average
of 1.5 records.
FDA concludes that the required
warnings for cigarette packages and
cigarette advertisements in § 1141.10 are
not subject to review by OMB because
they do not constitute a ‘‘collection of
information’’ under the PRA (44 U.S.C.
3501–3521). Rather, these labeling
statements are a ‘‘public disclosure’’ of
information originally supplied by the
Federal Government to the recipient for
the purpose of ‘‘disclosure to the
public’’ (5 CFR 1320.3(c)(2)).
Since our last request for OMB
approval, we have made no adjustments
to our burden estimate.
Dated: September 14, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–20196 Filed 9–16–22; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Hypertension Summit
Office on Women’s Health
(OWH), Office of the Assistant Secretary
for Health (OASH), Department of
Health and Human Services (HHS).
ACTION: Notice of event.
AGENCY:
The U.S. Department of
Health and Human Services’ Office on
Women’s Health (OWH) is providing
notice of a virtual Hypertension Summit
focused on innovations and evidence to
bridge practice gaps in the field of
hypertension treatment and prevention.
The purpose of the Hypertension
Summit is to exchange information
about this topic and seek input on an
individual basis from: patients who
have benefited from innovative
approaches to treating hypertension;
subject matter experts; Phase 1 awardees
of the HHS Hypertension Innovator
Award Competition; and members of
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:37 Sep 16, 2022
Jkt 256001
OWH’s Self-Measured Blood Pressure
Program (SMBP). This Hypertension
Summit will highlight research from the
Women’s Health Initiative that impacts
heart health and women’s health. This
Hypertension Summit is open to the
public. Individuals interested in
attending this Hypertension Summit
must register to attend as instructed
below.
OWH will host the Hypertension
Summit on October 19, 2022, during the
3rd annual observance of National
Women’s Blood Pressure Awareness
Week (NWBPAW), October 16–22, 2022.
ADDRESSES: The Hypertension Summit
will be held virtually.
FOR FURTHER INFORMATION CONTACT:
Contact Jeff Ventura at Womenshealth@
hhs.gov or 202–690–7650 or go to
https://www.womenshealth.gov/
hypertensionsummit for more
information.
DATES:
SUPPLEMENTARY INFORMATION:
Meeting Accessibility: The
Hypertension Summit will be held
virtually.
All attendees must register to receive
the virtual conference information for
the Hypertension Summit.
For more information on how to
register to attend, please visit https://
www.zoomgov.com/webinar/register/
WN_Z33WazyITyaeP29xVmyIKw.
Background: The HHS Office on
Women’s Health (OWH) is charged with
providing expert advice and
consultation to the Secretary concerning
scientific, legal, ethical, and policy
issues related to women’s health. OWH
establishes short-range and long-range
goals within the Department and
coordinates on activities within the
Department that relate to disease
prevention, health promotion, service
delivery, research, and public and
health care professional education, for
issues of particular concern to women
throughout their lifespan. OWH
monitors the Department’s activities
regarding women’s health and identifies
needs regarding the coordination of
activities. OWH is also responsible for
facilitating the exchange of information
through the National Women’s Health
Information Center. Additionally, OWH
coordinates efforts to promote women’s
health programs and policies with the
private sector. National Women’s Blood
Pressure Awareness Week (NWBPAW)
is an observance that focuses on
evidence to address practice gaps and to
improve women’s health outcomes
related to hypertension.
The Hypertension Summit will occur
during NWBPAW and will emphasize
the importance of blood pressure
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
57209
control. The Hypertension Summit will
facilitate the exchange information and
seek input on an individual basis from:
patients, who have benefited from
innovative approaches to treating
hypertension; subject matter experts;
Phase 1 awardees of the HHS
Hypertension Innovator Award
Competition; and members of OWH’s
Self-Measured Blood Pressure Program
(SMBP).
Topics covered during the
Hypertension Summit: The agenda will
be made up of several panels and
presentations focusing on the
innovations and evidence to bridge
practice gaps in the field of
hypertension treatment and prevention.
Topics may include, but are not limited
to, innovations and evidence to bridge
practice gaps in the field of
hypertension, self-measured blood
pressure, telehealth, technology, health
equity, hypertension in pregnancy and/
or postpartum, home-based care, and
health team integration.
The Hypertension Summit is open to
the public. Information regarding the
start and end times and any updates to
agenda topics will be available at
https://www.womenshealth.gov/
hypertensionsummit closer to the date
of the Hypertension Summit.
Procedures for Attendance: https://
www.zoomgov.com/webinar/register/
WN_Z33WazyITyaeP29xVmyIKw.
Dated: September 12, 2022.
Dorothy Fink,
Deputy Assistant Secretary for Women’s
Health, Office of the Assistant Secretary for
Health.
[FR Doc. 2022–20214 Filed 9–16–22; 8:45 am]
BILLING CODE 4150–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
E:\FR\FM\19SEN1.SGM
19SEN1
57210
Federal Register / Vol. 87, No. 180 / Monday, September 19, 2022 / Notices
lotter on DSK11XQN23PROD with NOTICES1
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Radiation Therapeutics and Biology.
Date: October 12, 2022.
Time: 1 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301)435–
3504, tothct@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group; Genetics
of Health and Disease Study Section.
Date: October 17–18, 2022.
Time: 9:30 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Payne, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 2208,
Bethesda, MD 20892, 301–402–3702,
christopher.payne@nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroscience and
Neurodegeneration Study Section.
Date: October 18–19, 2022.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan M. Moore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 451–0293,
jordan.moore@nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Science of Implementation in Health and
Healthcare Study Section.
Date: October 18–19, 2022.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenjuan Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3154,
Bethesda, MD 20892, (301) 480–8667,
wangw22@mail.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group; Basic
Biology of Blood, Heart and Vasculature
Study Section.
Date: October 20–21, 2022.
Time: 9 a.m. to 9 p.m.
VerDate Sep<11>2014
17:37 Sep 16, 2022
Jkt 256001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aisha Lanette Walker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3527, aisha.walker@
nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Developmental Therapeutics Study
Section.
Date: October 20–21, 2022.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4097, maureen.shuh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS.)
Dated: September 14, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20219 Filed 9–16–22; 8:45 am]
Date: October 18, 2022.
Time: 3:30 p.m. to 5:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIDDK–Review Branch, Democracy
2, 6707 Democracy Blvd., Suite 7017,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Maria E. Davila–Bloom,
Ph.D. Scientific Review Officer, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 7017, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7637 davila-bloomm@
extra.niddk.nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: September 14, 2022.
Miguelina Perez,
Program Analyst,Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20217 Filed 9–16–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Library of Medicine; Amended
Notice of Meeting
National Institutes of Health
Notice is hereby given of a change in
the meeting of the Literature Selection
Technical Review Committee, October
27–28, 2022, 9:30 a.m. to 5:00 p.m.,
which was published in the Federal
Register on July 1, 2022, 87 FR 126,
Page 39538.
This meeting will be amended to
change the meeting time from 9:30 a.m.–
5:00 p.m. to 10:00 a.m.–4:00 p.m. on
both days. An open session is added
from 10:00–11:20 a.m. on October 28,
2022.
The open session of the meeting will
be virtual. Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify Dianne
Babski, Associate Director, Division of
Library Operations, National Library of
Medicine at babskid@mail.nih.gov. The
open session will be videocast and can
be accessed from the NIH Videocasting
website (NIH VideoCast—LSTRC
Meeting).
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel RC2 on Intestinal
Biology.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
E:\FR\FM\19SEN1.SGM
19SEN1
]]>Agencies
[Federal Register Volume 87, Number 180 (Monday, September 19, 2022)]
[Notices]
[Pages 57209-57210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 57210]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Radiation Therapeutics and Biology.
Date: October 12, 2022.
Time: 1 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301)435-3504, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genetics of Health and Disease Study Section.
Date: October 17-18, 2022.
Time: 9:30 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Payne, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 2208, Bethesda, MD 20892, 301-402-
3702, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Clinical Neuroscience and Neurodegeneration
Study Section.
Date: October 18-19, 2022.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan M. Moore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
451-0293, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Science of Implementation in Health and
Healthcare Study Section.
Date: October 18-19, 2022.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenjuan Wang, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480-8667,
[email protected].
Name of Committee: Vascular and Hematology Integrated Review
Group; Basic Biology of Blood, Heart and Vasculature Study Section.
Date: October 20-21, 2022.
Time: 9 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aisha Lanette Walker, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3527,
[email protected].
Name of Committee: Biology of Development and Aging Integrated
Review Group; Developmental Therapeutics Study Section.
Date: October 20-21, 2022.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-4097,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS.)
Dated: September 14, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-20219 Filed 9-16-22; 8:45 am]
BILLING CODE 4140-01-P
